Axsome: Q2 Earnings Snapshot

Axsome Therapeutics Inc. reported a second quarter loss of $51.3 million, equating to 99 cents per share, which met Wall Street expectations. While revenue reached $218.4 million, it fell short of Street forecasts and the average estimate of $224.5 million from seven analysts.